Report on Activities for the Quarter ended 30 September 2022 24 October 2022 by Audrey Thomson Report on Activities for the Quarter Ended 30 September 2022
Quarterly Report 30 September 2022 24 October 2022 by Audrey Thomson Quarterly Report 30 September 2022
Second BIT225 Phase 2 HIV-1 Clinical Trial Fully Recruited 4 October 2022 by Audrey Thomson Second BIT225 Phase 2 HIV-1 Clinical Trial Fully Recruited
BIT225 COVID-19 Human Study Commenced 14 September 2022 by Audrey Thomson BIT225 COVID-19 Human Study Commenced
BIT225 Phase 2 HIV-1 Clinical Trial Fully Recruited 23 August 2022 by Audrey Thomson BIT225 Phase 2 HIV-1 Clinical Trial Fully Recruited
Year End Accounts and Preliminary Final Report 19 August 2022 by Audrey Thomson Year End Accounts and Preliminary Final Report
Appendix 4G and Corporate Governance Statement 19 August 2022 by Audrey Thomson Appendix 4G and Corporate Governance Statement 2022
Report on Activities for the Quarter ended 30 June 2022 28 July 2022 by Audrey Thomson Report on Activities for the Quarter Ended 30 June 2022
